Convert Catalysts Into Profits: Sagient Research's Edward Stopke
January 25, 2015 at 07:43 AM EST
The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline products is the healthy approach for selecting a winner.
